DSGN FY 2025 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DSGNDesign Therapeutics, Inc.

$569M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$79M

Net Income

-$70M

EPS (Diluted)

$-1.22

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$55M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$226M

Total Liabilities

$14M

Stockholders' Equity

$213M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$596,000	+100.0%
Operating Income	-$79M	-$62M	-27.4%
Net Income	-$70M	-$50M	-40.7%